Testing effectiveness (Phase 2)Ended earlyNCT00791154
What this trial is testing
QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer
Who this might be right for
Lung CancerSmall Cell Lung CancerSolid Tumors+1 more
NantCell, Inc. 213